Generate a tailored SOP for Dr. Daniel Lamarre. Improve your application with a focused, well-structured draft.
Trained in biochemistry at the University of Montreal and then at the University of Sherbrooke, Daniel Lamarre has been involved with the research team at the Centre hospitalier de l’Université de Montréal (CHUM). His expertise lies primarily in the understanding of liver diseases, particularly hepatitis C, and he has established a reputation for developing new antiviral drugs. He is a key researcher at the Institute of Research in Immunology and Cancer, where he leads initiatives focused on screening compounds for potential therapeutic agents. With decades of experience in virology and molecular biology, he has contributed significantly to the field, particularly in understanding how viruses escape immune responses. As a professor at the University of Montreal, he emphasizes the need for multidisciplinary collaboration to enhance research outcomes. His leadership role encompasses overseeing significant research projects concerning the hepatitis C virus and its interactions with the immune system.
University of Montreal • Montreal, QC, Canada
Teaching and conducting research in virology and immunology.
Boehringer Ingelheim • Canada
Lead research on HIV and HCV related antiviral compounds.
Most programs require French B2 level; specific departments may require C1 or C2.